The 5 Tumor Markers You Must Know About Lung Cancer - Mindray Global
What are common tumor markers? - Quora
Association of Divergent Carcinoembryonic Antigen Patterns and Lung Cancer Progression | Scientific Reports
Clinical characteristics, CTC count, and tumor markers of lung cancer... | Download Table
Significance of combined detection of LunX mRNA and tumor markers in diagnosis of lung carcinoma - Chinese Journal of Cancer Research
Tumor marker levels in serum of lung cancer patients at different stages. | Download Table
Oncology
Recommendations for use of markers according to histologies of lung... | Download Table
Useful and potentially useful markers for lung cancer. | Download Table
Clinical relevance of molecular markers in lung cancer - ScienceDirect
Combination of Circulating Tumor Cells with Serum Carcinoembryonic Antigen Enhances Clinical Prediction of Non-Small Cell Lung Cancer | PLOS ONE
Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy - ScienceDirect
PDF) National Academy of Clinical Biochemistry Guidelines for the Use of Tumor Markers in Lung Cancer
Prognostic markers in lung cancer: is it ready for prime time? - Zhu - Translational Lung Cancer Research
폐암 연구를 위한 BIO-Marker 총정리 (Biomarker for lung cancer research) - 서린바이오사이언스
Serum APE1 Autoantibodies: A Novel Potential Tumor Marker and Predictor of Chemotherapeutic Efficacy in Non-Small Cell Lung Cancer | PLOS ONE
Clinical Utility of Tumor Markers
Combining PET/CT with serum tumor markers to improve the evaluation of histological type of suspicious lung cancers | PLOS ONE
Molecular markers to predict clinical outcome and radiation induced toxicity in lung cancer - Palmer - Journal of Thoracic Disease
Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer. | Semantic Scholar
List of reviewed tumour markers in lung cancer | Download Table
Table 4 from Tumor Markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in Patients with Non-Small Cell Lung Cancer as an Aid in Histological Diagnosis and Prognosis | Semantic Scholar
CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma | PLOS ONE
Frontiers | Clinical Evaluation of Serum Tumor Markers in Patients With Advanced-Stage Non-Small Cell Lung Cancer Treated With Palliative Chemotherapy in China
